doi : 10.1111/ijd.15756
International Journal of DermatologyVolume 60, Issue 8 p. 913-914
Karolina Kozubowska MD,Martyna S?awi?ska MD, PhD,Micha? Sobjanek MD, PhD
doi : 10.1111/ijd.15315
International Journal of DermatologyVolume 60, Issue 8 p. 915-924
The role of dermoscopy in dermatology is constantly evolving. Relatively little is known about its application in diagnosis of dermatological conditions of the eyelid, eyelashes, and conjunctiva. The aim of the study is to summarize the existing knowledge in this field.
Jason J. Yang BS,Donald K. Lei MS,Vignesh Ravi BA,Nolan J. Maloney MD,Ashley Crew MD,Scott Worswick MD
doi : 10.1111/ijd.15196
International Journal of DermatologyVolume 60, Issue 8 p. 925-932
Drug reaction and eosinophilia with systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome (DIHS), shares features with hemophagocytic lymphohistiocytosis (HLH), most notably fever, rash, and internal organ involvement. However, there is increasing recognition of drug-induced (secondary) HLH and biopsy-proven hemophagocytosis in DRESS, suggesting that HLH and DRESS not only overlap but also may be diseases on the same spectrum of immune dysfunction. To characterize existing literature on HLH/DRESS overlap, we queried the PubMed/MEDLINE database for 23 cases of HLH-DRESS codiagnosis. Average time-to-onset of rash after exposure to inciting drug was 2.7 weeks. Fourteen cases (61%) clinically worsened despite initial therapy, prompting a workup with diagnosis of HLH on average 2.3 weeks after diagnosing DRESS. Nine cases met HLH diagnostic criteria and had a RegiSCAR score ?4. Nine cases met one set of criteria with a presentation suggestive of the other. Five cases met neither criteria. A patient presenting with fever, generalized rash, bicytopenia, and internal organ involvement after drug exposure was most predictive of meeting diagnostic criteria for both HLH and DRESS. Treatment was highly variable, although most initiated systemic corticosteroids with/without IVIG, plasmapheresis, or etoposide. Patients with poor outcomes in this review were treated using steroid monotherapy and had viral reactivation. Dermatologists should consider the possibility of HLH in any patient presenting with fever, rash, internal organ involvement, and cytopenia. Additional studies will be necessary to further characterize HLH and DRESS overlap and determine optimal management.
Andrea Sechi MD,Annalisa Patrizi MD,Francesco Savoia MD, PhD,Miriam Leuzzi MD,Alba Guglielmo MD,Iria Neri MD
doi : 10.1111/ijd.15301
International Journal of DermatologyVolume 60, Issue 8 p. 933-943
Terra firma-forme dermatosis (TFFD) is an acquired pigmentation disorder that promptly regresses after applying isopropyl alcohol 70%. The clinical presentation ranges from patches of brownish discoloration to velvety hyperkeratotic plaques. Critical analyses of current data are lacking, so etiologies, pathogenesis, and disease associations are still debated in the literature. A literature search was done in the PubMed and Google Scholar databases to identify the published papers reporting clinical cases of TFFD. Of 102 papers screened, 64 met the including criteria. Overall, the records of 256 patients presenting a mean age of 18.34 years and a female:male ratio of 1:37 were reviewed. The present article aims to provide a key point-summary regarding the clinical outcome, associated comorbidities, pathogenesis, histopathology, dermoscopy, and therapeutic modalities of TFFD.
Carla Stephan MD,Mazen Kurban MD,Ossama Abbas MD
doi : 10.1111/ijd.15385
International Journal of DermatologyVolume 60, Issue 8 p. 944-950
Dowling-Degos disease is a rare autosomal dominant genodermatosis. It is characterized by acquired reticulate hyperpigmentation over the flexures, comedone-like follicular papules, and pitted perioral scars that usually develop during adulthood. Mutations in genes affecting melanosome transfer, and melanocyte and keratinocyte differentiation have been implicated in the pathogenesis of this disease. These genes include KRT5, POFUT1, POGLUT1 and, most recently, PSENEN. Dowling-Degos disease can be found in isolation or with other associated findings, most notably hidradenitis suppurativa. This condition belongs to a spectrum of conditions that all result in reticulate hyperpigmentation that at times are hard to distinguish from each other. The most closely linked entity is Galli-Galli, which is clinically indistinguishable from Dowling-Degos disease and can only be distinguished by the presence of acantholysis on microscopy. Unfortunately, Dowling-Degos disease is generally progressive and recalcitrant to treatment.
Eduardo Rozas-Mu?oz MD,Cristina L?pez-S?nchez MD,Jaime Piquero-Casals MD,Esther Roé MD,Juan F. Mir-Bonafé MD
doi : 10.1111/ijd.15336
International Journal of DermatologyVolume 60, Issue 8 p. 951-952
Chee Hoou Loh MD, MRCP (UK),Po Yin Tang MBBS, BMedSc, FRCPA, FRCPath,Haur Yueh Lee MBBS, MRCP (UK), MMed (Int Med), FAMS (Dermatology)
doi : 10.1111/ijd.15455
International Journal of DermatologyVolume 60, Issue 8 p. 953-955
Jorge Ocampo-Candiani MD, PhD,Cesar Jair Ramos-Cavazos MD,Maria Ivonne Arellano-Mendoza MD, MSc,Roberto Arenas-Guzm?n MD,Angélica Beirana-Palencia MD,Alfredo Salmon-Demongin MD,Esperanza Welsh-Hern?ndez MD,Horacio A. Cabo MD,Minerva G?mez-Flores MD, PhD,Judith Dominguez-Cherit MD,Paulo Ricardo Criado MD,Helena Castro-L?pez MD,Abraham Benjamin Alfaro-S?nchez MD,Alejandro Garc?a-Vargas MD,Emilia N. Cohen-Sabban MD,Manuel del Solar MD,Félix Fich MD,Gast?n Galimberti MD,Carlos Fernando Gatti MD,José Luis L?pez-Estebaranz MD,Omar Lupi MD,Miguel Olmos-Pérez MD,Ricardo Pérez-Alfonzo MD
doi : 10.1111/ijd.15632
International Journal of DermatologyVolume 60, Issue 8 p. 956-963
The infection by coronavirus disease 2019 (COVID-19) has been associated with multiple cutaneous manifestations, although characterization of them in Hispanic patients with darker skin phototypes is lacking. The objective of this study is to characterize the clinical dermatological manifestations associated with COVID-19 infection in cases with few or without general symptoms in patients from Latin America.
Ting-Jung Hsu MD,Hsu-Hang Yeh MD,Chih-Hung Lee MD, PhD,Kwei-Lan Liu MD
doi : 10.1111/ijd.15586
International Journal of DermatologyVolume 60, Issue 8 p. 964-972
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are potentially fatal adverse drug reactions. The characteristics of these diseases are changing with the use of novel drugs, posing new challenges to doctors. We aimed to review recent SJS/TEN cases in order to assist general practitioners with timely diagnosis and correct management.
Wafaa Ahmed Shehata MD,Alaa Maraee MD,Manal Abd El Monem Ellaithy MD,Nermin Tayel PhD,Asmaa Abo-Ghazala MBBCh,Sally Mohammed El-Hefnawy MD
doi : 10.1111/ijd.15494
International Journal of DermatologyVolume 60, Issue 8 p. 973-979
The current study aims at evaluating the role of circulating or cell-free long noncoding ribonucleic acid (lncRNA) growth arrest-specific 5 (GAS5) in plaque psoriasis and at investigating its relationship with the presented clinical data.
Sema E. Aksac MD,Serap G. Bilgili MD,Goknur O. Yavuz MD,Ibrahim H. Yavuz MD,Murat Aksac MD,Ayse S. Karadag MD
doi : 10.1111/ijd.15485
International Journal of DermatologyVolume 60, Issue 8 p. 980-985
Impairment of biotin metabolism with the use of isotretinoin and the mucocutaneous side effects observed in patients using isotretinoin suggests that they are a result of decreased enzyme activity. We aimed to determine the pattern of skin and hair changes in patients with acne receiving isotretinoin and how these changes were affected by biotin added to the treatment.
Leila M. Tolaymat MD,Danielle K. Reimer MD,Joshua Feig,Melinda S. Gillis MEd,Leigh L. Speicher MD, MPH,Claire B. Haga MD,Emmanuel M. Gabriel MD, PhD,Michael G. Heckman MS,Mingyuan Yin MHA,Scott W. Fosko MD,Andrew P. Keaveny MD,Nancy L. Dawson MD
doi : 10.1111/ijd.15519
International Journal of DermatologyVolume 60, Issue 8 p. 986-990
Limited data are available on the development of skin cancer and the associated risk factors for non-White liver transplant (LT) recipients. The aim of this study is to determine the incidence of newly diagnosed skin cancer postoperatively and to identify the risk factors for the development of skin cancer in non-White LT recipients.
Yu Fu MD,Yingqiu Bao MD,Ziyuan Li MD,Xiaoman Gao MD,Jianmin Chang MD
doi : 10.1111/ijd.15555
International Journal of DermatologyVolume 60, Issue 8 p. 991-995
This study aimed to analyze changes in melanocyte density and epidermal thickness in vulvar lichen sclerosus (VLS).
Claudio Conforti MD,Roberta Giuffrida MD,Marina Agozzino MD,Patrizia Serafinella Cannav? MD,Caterina Dianzani MD,Nicola di Meo MD,Carlotta Nardello MD,Nicoleta Neagu MD, MSc,Fabrizio Guarneri MD,Iris Zalaudek MD
doi : 10.1111/ijd.15554
International Journal of DermatologyVolume 60, Issue 8 p. 996-1002
Basal cell carcinoma (BCC) and dermal nevi located on the face can easily be confused on clinical examination. Little is known about the different preferential localizations of these entities, and a systematic analysis of dermatoscopic features for differential diagnosis is lacking.
Thais Silva Matos MSc,Vanessa Almeida do Nascimento MSc,Rodrigo Feliciano do Carmo PhD,Tânia Rita Moreno de Oliveira Fernandes MD, PhD,Carlos Dornels Freire de Souza PhD,Tarc?sio Fulgêncio Alves da Silva PhD
doi : 10.1111/ijd.15705
International Journal of DermatologyVolume 60, Issue 8 p. 1003-1006
This study analyzed the impact of the COVID-19 pandemic on the detection of new cases of leprosy in the state of Bahia, Brazil. The periods January–September 2019 and January–September 2020 were compared. There was a 44.40% reduction in the diagnosis of leprosy when comparing the two periods (1,705 in 2019 and 948 in 2020). There was a reduction in the number of municipalities with reported cases: 251 municipalities in 2019 and 202 in 2020, expressing a reduction of 24.25%. Considering only the months following the arrival of the virus (April–September), the reduction was 51.10%. An inverse correlation was observed between the number of new cases of leprosy and the cumulative number of cases of COVID-19 (Spearman's correlation coefficient = ?0.840; P < 0.001) and the number of new monthly cases of COVID-19 (Spearman's correlation coefficient = ?0.817; P < 0.001). A slight increase was also observed in the proportion of multibacillary cases in the state (70.38% in 2019 and 72.69% in 2020) as well as in the proportion of individuals with the degree of physical disability not assessed at diagnosis, whose proportion rose from 16.39% in 2019 to 22.53% in 2020. The negative impact of COVID-19 in tackling leprosy should be seen as a warning sign for health and political authorities.
Héctor Perandones-Gonz?lez MD,Teresa Alonso-Alonso MD,Soledad Medina-Valdivieso MD,Rubén Linares-Navarro MD,Samuel S?ez-?lvarez MD,Judith Montanchez-Mateo MD
doi : 10.1111/ijd.15627
International Journal of DermatologyVolume 60, Issue 8 p. 1007-1009
Vitaly Terushkin MD,David G. Brodland MD,Danny J. Sharon MS,John A. Zitelli MD
doi : 10.1111/ijd.15533
International Journal of DermatologyVolume 60, Issue 8 p. 1010-1012
Merkel cell carcinoma (MCC) of the skin is most commonly treated with wide local excision (WLE) with or without adjuvant radiation therapy (RT). Mohs micrographic surgery (MMS) as monotherapy may offer an alternative treatment modality. The purpose of this study is to describe outcomes of patients with primary Stage I/II MCC treated with MMS alone and no RT.
Siswanto Wahab MD, PhD,Anis I. Anwar MD, PhD,Andi N. Zainuddin MD,Emma N. Hutabarat MD,Asvina A. Anwar MD,Ivan Kurniadi MD, BmedSci (Hons)
doi : 10.1111/ijd.15573
International Journal of DermatologyVolume 60, Issue 8 p. 1013-1018
The antimelanogenesis effect of topical and oral glutathione has been shown in several in vitro and clinical studies. However, whether combination of topical and oral glutathione is superior to topical or oral monotherapy is unknown. This study aimed to compare the skin-whitening effect of topical and oral glutathione combination therapy against topical and oral monotherapy.
David M. Weiner AB,William D. James MD
doi : 10.1111/ijd.15550
International Journal of DermatologyVolume 60, Issue 8 p. 1019-1027
Agostina Alonzo Caldarelli MD,Paula Barba MD,Mariana Hurtado MD
doi : 10.1111/ijd.15598
International Journal of DermatologyVolume 60, Issue 8 p. 1028-1029
Fouzia Hali PhD,Houda Jabri MD,Soumiya Chiheb PhD,Yassine Hafiani PhD,Afak Nsiri PhD
doi : 10.1111/ijd.15592
International Journal of DermatologyVolume 60, Issue 8 p. 1030-1031
Stephanie R. Cohen MD,Lisa Prussick MD,Jared S. Kahn MS, BS,David X. Gao BA,Arash Radfar MD,David Rosmarin MD
doi : 10.1111/ijd.15623
International Journal of DermatologyVolume 60, Issue 8 p. 1032-1033
Shigeto Yanagihara MD, PhD,Naoki Oiso MD, PhD,Akira Kawada MD, PhD
doi : 10.1111/ijd.15601
International Journal of DermatologyVolume 60, Issue 8 p. 1034-1035
Malena Gergovska MD, PhD,Karen Manuelyan MD, PhD,Mariela Hitova MD, PhD,Jana Kazandjieva MD, PhD
doi : 10.1111/ijd.15552
International Journal of DermatologyVolume 60, Issue 8 p. 1036-1037
Tal Goldberger MD,Gil Armoni MD,David Lavie MD,Sharon Merims MD,Alexander Maly MD,Rony Shreberk-Hassidim MD
doi : 10.1111/ijd.15563
International Journal of DermatologyVolume 60, Issue 8 p. 1038-1039
Ranthilaka R. Ranawaka MBBS, MD
doi : 10.1111/ijd.15567
International Journal of DermatologyVolume 60, Issue 8 p. 1040-1041
Antonella Tammaro MD,Francesca Magri MD,Ganiyat A. R. Adebanjo MD,Francesca R. Parisella MD,Camilla Chello MD,Jordi Rello MD, PhD,Sergio Ramirez-Estrada MD, PhD
doi : 10.1111/ijd.15746
International Journal of DermatologyVolume 60, Issue 8 p. 1042-1043
Trisha Khanna MD,Graham H. Litchman DO,Sadia Saeed MD,Rajiv Nathoo MD
doi : 10.1111/ijd.15325
International Journal of DermatologyVolume 60, Issue 8 p. e291-e293
Paula Gerlero MD,Isabella Doche MD, PhD,Marina Rebeis MD,Thalita Macedo MD,Maria C. Rivitti-Machado MD
doi : 10.1111/ijd.15465
International Journal of DermatologyVolume 60, Issue 8 p. e294-e296
Mar?a Arteaga-Henr?quez MD,Leonie Frommherz MD,Judith Fischer MD, PhD,Cristina Has MD
doi : 10.1111/ijd.15599
International Journal of DermatologyVolume 60, Issue 8 p. e296-e297
Keegan O’Hern BA,Meagan Chambers MD, MS, MSc,Chenin Ryan BS, MS,M. Shane Chapman MD, MBA
doi : 10.1111/ijd.15261
International Journal of DermatologyVolume 60, Issue 8 p. e297-e299
Yanan Li DDS,Rui Du DDS,Beibei Cong DDS,Yingjie Xu DDS,Wenyi Zhang DDS
doi : 10.1111/ijd.15404
International Journal of DermatologyVolume 60, Issue 8 p. e299-e301
Laura Steinmayer MD,Irène Nicoletis MD,Sophie Leducq MD,Dominique Verdier MD,Benjamin Faivre MD,Guillaume Desoubeaux PhD,Mahtab Samimi MD, PhD
doi : 10.1111/ijd.15562
International Journal of DermatologyVolume 60, Issue 8 p. e301-e302
Angela Ayén-Rodriguez MD,Alberto Benavente-Fernandez MD,Daniel S?nchez-Cano MD, PhD,Ricardo Ruiz-Villaverde MD, PhD
doi : 10.1111/ijd.15428
International Journal of DermatologyVolume 60, Issue 8 p. e302-e304
Catarina Correia MD,Rita Mendes MD,Maria Sanches MD,S?nia Fernandes MD,Lu?s Soares-Almeida MD, PhD,Jo?o Borges-Costa MD, PhD,Paulo Filipe MD, PhD
doi : 10.1111/ijd.15548
International Journal of DermatologyVolume 60, Issue 8 p. e304-e306
Biswanath Behera MD, DNB,Rashmi Kumari MD,Devinder Mohan Thappa MD,Debasis Gochhait MD, DNB,Pavithra Ayyanar MD, DNB
doi : 10.1111/ijd.15413
International Journal of DermatologyVolume 60, Issue 8 p. e306-e308
Wei Xuan Tan,Ki Wei Tan MBBS, MRCP(UK), FAMS,Yong Kwang Tay MBBS, FRCP (London), MMed (Int Med), FAMS,Chia Chun Ang MBBS, MRCP (UK), MMed (Int Med), FAMS
doi : 10.1111/ijd.15484
International Journal of DermatologyVolume 60, Issue 8 p. e309-e311
Kamran Balighi MD,Mani Dastgheib MD,Alireza Ghannadan MD,Pooneh Y. Qadikolaee MD,Shahin Hamzelou MD
doi : 10.1111/ijd.15486
International Journal of DermatologyVolume 60, Issue 8 p. e311-e313
Vieri Grandi MD,Irene Lastrucci MD,Susanna Gunnella MD,Chiara Delfino MD,Nicola Pimpinelli MD, PhD
doi : 10.1111/ijd.15462
International Journal of DermatologyVolume 60, Issue 8 p. e313-e315
Yoshio Kawakami MD,Masao Mitsui MD,Hitoshi Takamoto MD,Yasuo Yamamoto MD
doi : 10.1111/ijd.15420
International Journal of DermatologyVolume 60, Issue 8 p. e315-e317
Raquel Sampedro-Ruiz MD,Luisa Martos-Cabrera MD,Javier Fraga-Fern?ndez MD,Maximiliano Aragüés MD,Pablo Chicharro MD
doi : 10.1111/ijd.15453
International Journal of DermatologyVolume 60, Issue 8 p. e317-e319
Peter Kin Cho Goon PhD, FRCP,Hai-Yee Lim RGN,Liz Summerfield RGN,Cedric Charles Banfield MB, FRCP,Holger Sudhoff MD, PhD, FRCS, FRCPath,Dick Mallett MB, FRCP
doi : 10.1111/ijd.15560
International Journal of DermatologyVolume 60, Issue 8 p. e319-e320
Justine R. Seivright BS,Melodyanne Y. Cheng MS,Natalie M. Villa MD,Vivian Y. Shi MD,Jennifer L. Hsiao MD
doi : 10.1111/ijd.15401
International Journal of DermatologyVolume 60, Issue 8 p. e320-e323
Jennifer M. Fernandez BS, RD,Omar H. Rizvi MS,Kendra D. Marr BS,Aleksi J. Hendricks BS,Melody Maarouf MD, MHS,Kyla N. Price BS,Catherine M. Ludwig BS,Jennifer L. Hsiao MD,Vivian Y. Shi MD
doi : 10.1111/ijd.15377
International Journal of DermatologyVolume 60, Issue 8 p. e323-e325
Nessa Aghazadeh MD,Nora S. Ali MD,Lawrence E. Gibson MD,Margot S. Peters MD
doi : 10.1111/ijd.15399
International Journal of DermatologyVolume 60, Issue 8 p. e325-e326
Natalie M. Villa MD,Justine R. Seivright BS,Scott D. Worswick MD,Vivian Y. Shi MD,Jennifer L. Hsiao MD
doi : 10.1111/ijd.15434
International Journal of DermatologyVolume 60, Issue 8 p. e326-e331
Elizabeth Schoenberg MD,Beth Colombe PhD,Jisun Cha MD,Marlana Orloff MD,Doaa Shalabi MD,Nicholas A. Ross MD,Bahar Dasgeb MD
doi : 10.1111/ijd.15405
International Journal of DermatologyVolume 60, Issue 8 p. e331-e333
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟